Cancer is costing BRICS economies billions each year

January 24, 2018 by Alison Pearce, The Conversation
The cancer Kaposi sarcoma. South Africa has large productivity losses because of deaths caused by it. Credit: Shutterstock

Premature – and potentially avoidable – death from cancer is costing tens of billions of dollars in lost productivity in a group of key developing economies.

Over two-thirds of the world's deaths occur in economically developing countries, but the societal of the disease have rarely been assessed in these settings.

In a paper published today in the Journal of Cancer Epidemiology we show that the total cost of lost because of premature cancer mortality for Brazil, Russia, India, China and South Africa – known as BRICS – was USD$46.3 billion in 2012. (This was the most recent year for which cancer data was available for all these countries.)

The BRICS countries are a diverse group of nations but were originally grouped together because they were rising emerging economies. Currently the five countries combined comprise over 40% of the world's population and 25% of global gross domestic product.

South Africa has the highest cost per cancer death (USD$101,000) compared with the other BRICS countries. Its cost is five times that of India, which had the lowest cost per death. Given the size of China's population it has the largest overall loss (USD$28 billion).

Our research found that liver and lung cancers had the largest impact on total lost productivity across the BRICS countries due to their high incidence. In South Africa, there are high productivity losses per death due to a form of cancer – Kaposi sarcoma – that people with AIDS are particularly vulnerable to. This highlights the extent of the HIV/AIDS epidemic in Sub-Saharan Africa.

Tobacco and infection-related cancers (such as liver, cervical, stomach cancers and Kaposi sarcoma) were major contributors to productivity losses across all five countries. Many of these are amenable to prevention, early detection or treatment. But most developing countries don't have such programmes.

Our research underscores the fact that policies encouraging lifestyle changes which reduce the risk of cancer could have positive effects on the BRICS countries' economies. Combining tobacco control, vaccination programmes and cancer screening with access to adequate treatment could yield significant gains for both public health as well as economic performance.

Calculating the cost

Beyond the public health impact, cancer also imposes economic costs on individuals and society. These costs include lost productivity caused by society losing the contribution of an individual to the economy because they died prematurely from cancer.

Valuing this lost production gives policy and decision makers an additional perspective when identifying priorities for cancer prevention and control. Locally tailored strategies could reduce the economic burden of cancer.

We used cancer statistics compiled by the World Health Organisation's International Agency for Research on Cancer to get the number of cancer deaths in 2012 for each country. We then estimated the number of additional years each person could have been productive (up until average retirement age), had they not died of cancer. Finally, we used national workforce data, such as the unemployment rate and average wages, to value the years of lost productivity.

The economic impact of cancer in countries can obviously differ for a range of reasons. These include variations in demography, exposure to cancer risk factors and economic environments. This means each country will have its own unique patterns of productivity loss.

In South Africa the five cancers resulting in the greatest productivity loss were lung cancer, cervical cancer, breast cancer, Kaposi sarcoma and oesophageal cancer. Lung and cervical cancer had a particularly large economic impact.

In Brazil, lung cancer resulted in the greatest productivity losses. Rapidly growing rates of obesity in Brazil were also a contributory factor.

Both liver and head and neck cancers contributed to the high number of deaths in Russia. In India, lip and oral cancers dominated lost productivity. The lost productivity costs per leukaemia were also relatively high. This could be because the advanced, multi-modality treatments required are not available or are difficult to access.

In China productivity lost due to cancer was USD$26 billion in 2012, more than all the other BRICS countries combined. Two-thirds of the costs were in urban areas (66%), considerably more than the proportion of people who reside in urban areas (52%).

Workforce and productivity are key resources in ensuring sustained economic growth, particularly in developing countries such as the five we studied. Understanding the local priorities for cancer prevention and control can play a big part in the economic health of these countries.

Explore further: Cancer in EU cost EUR126 billion in 2009

Related Stories

Cancer in EU cost EUR126 billion in 2009

October 13, 2013
The results, published in The Lancet Oncology, reveal substantial disparities between different countries in the EU in spending on health care and drugs for cancer, with Luxembourg and Germany spending the most on health ...

Cancer costs billions yearly in U.S. worker productivity, study finds

December 17, 2012
(HealthDay)—The cost of lost productivity among U.S. workers with cancer is equal to 20 percent of the nation's health care spending, according to a new study.

Research shows high cancer death rates in Asia

June 8, 2016
Asia has one of the lowest overall cancer rates globally, but cancer patients are more likely to die there than most other regions.

Smoking gobbles up almost six percent of global health spend and nearly two percent of world's GDP

January 30, 2017
Smoking consumes almost 6 per cent of the world's total spend on healthcare and nearly 2 per cent of global GDP, reveals the first study of its kind, published in the journal Tobacco Control.

Cancer cases set to rise by half by 2030

February 3, 2014
New cases of cancer will rise by half by 2030, reaching 21.6 million per year compared to 14 million in 2012, the UN said on Monday in a global analysis of the scourge.

Cancer rates decline in many high-income countries, but rise in lower-income countries

December 14, 2015
Improved screening and detection efforts, combined with decreases in risk factors like smoking, have reduced the incidence and mortality rates from several common types of cancer in many high-income countries. However, many ...

Recommended for you

DNA vaccine leads to immune responses in HPV-related head and neck cancer

September 21, 2018
A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center of the University of ...

In zebrafish, a way to find new cancer therapies, targeting tumor modulators

September 21, 2018
The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes. Looking for a way to test for their presence in zebrafish, their go-to research ...

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.